FDA Inspection 1021037 — Osteotech, Inc.

Osteotech, Inc. — FEI 3002600221

The FDA completed an inspection of Osteotech, Inc. on Aug 10, 2017 in Eatontown, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 10, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Eatontown, NJ (United States)

Citations

IDCFRDescription
1232521 CFR 1271.160(b)(6)Deviations--evaluation, cause, corrective action
1235921 CFR 1271.195(a)(3)Aseptic processing---cleaning, disinfecting
1236421 CFR 1271.195(c)Monitoring-microorganisms where appropriate

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.